|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 382.80 GBX | -0.31% |
|
-0.57% | +1.43% |
| 06-24 | Haleon plc Announces Executive Changes | CI |
| 06-13 | S&P 500 Suffers Weekly Drop as Israel, Iran Launch Attacks | MT |
| Capitalization | 34.4B 46.83B 40.32B 37.67B 64.21B 4,024B 72.13B 446B 171B 1,854B 176B 172B 6,780B | P/E ratio 2025 * |
21.8x | P/E ratio 2026 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 41.87B 56.99B 49.07B 45.85B 78.14B 4,897B 87.79B 543B 209B 2,257B 214B 209B 8,252B | EV / Sales 2025 * |
3.72x | EV / Sales 2026 * | 3.5x |
| Free-Float |
89.25% | Yield 2025 * |
1.83% | Yield 2026 * | 2.04% |
More valuation ratios
* Estimated data
More news
Last Transcript: Haleon plc
More recommendations
More press releases
More news
| 1 day | -0.31% | ||
| 1 week | -2.10% | ||
| Current month | -7.51% | ||
| 1 month | -7.00% | ||
| 3 months | -2.60% | ||
| 6 months | +0.58% | ||
| Current year | +1.43% |
| 1 week | 381.1 |  | 388.5 |
| 1 month | 381.1 | | 419.5 |
| Current year | 354.2 | | 419.5 |
| 1 year | 320 | | 419.5 |
| 3 years | 241.17 | | 419.5 |
| 5 years | 241.17 | | 419.5 |
| 10 years | 241.17 | | 419.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian McNamara
CEO | Chief Executive Officer | 58 | 21/07/2021 |
Dawn Allen
DFI | Director of Finance/CFO | 55 | 31/10/2024 |
Claire Dickson
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian McNamara
BRD | Director/Board Member | 58 | 22/05/2022 |
Vindi Banga
BRD | Director/Board Member | 70 | 17/07/2022 |
Tracy Clarke
BRD | Director/Board Member | 58 | 17/07/2022 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.94% | 4 M€ | +20.40% | - | |
| 0.79% | 57 M€ | +11.89% | - | |
| 0.43% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.31% | -2.10% | +14.61% | - | 46.6B | ||
| +0.97% | -3.65% | -11.97% | +148.81% | 692B | ||
| +0.57% | -1.95% | +2.31% | -15.29% | 364B | ||
| +0.97% | -2.78% | +8.90% | +24.16% | 325B | ||
| +0.53% | -9.04% | -54.14% | +18.77% | 310B | ||
| +0.61% | -0.30% | +3.68% | -14.43% | 257B | ||
| +0.36% | -0.99% | +1.52% | +21.97% | 229B | ||
| -0.84% | -4.49% | -17.16% | -0.46% | 218B | ||
| +0.20% | -0.79% | -38.56% | -12.70% | 201B | ||
| +1.85% | -6.11% | -9.95% | +14.15% | 146B | ||
| Average | +0.38% | -4.36% | -10.08% | +20.55% | 278.91B | |
| Weighted average by Cap. | +0.33% | -4.97% | -11.58% | +40.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 11.25B 15.31B 13.18B 12.32B 20.99B 1,316B 23.59B 146B 56.07B 606B 57.41B 56.24B 2,217B | 11.74B 15.97B 13.75B 12.85B 21.9B 1,373B 24.6B 152B 58.5B 632B 59.89B 58.67B 2,313B |
| Net income | 1.61B 2.19B 1.89B 1.76B 3.01B 188B 3.38B 20.88B 8.03B 86.8B 8.22B 8.05B 317B | 1.74B 2.37B 2.04B 1.91B 3.25B 204B 3.65B 22.59B 8.68B 93.9B 8.89B 8.71B 343B |
| Net Debt | 7.47B 10.16B 8.75B 8.18B 13.94B 873B 15.65B 96.82B 37.22B 402B 38.1B 37.33B 1,471B | 6.7B 9.12B 7.85B 7.34B 12.5B 784B 14.05B 86.87B 33.39B 361B 34.19B 33.49B 1,320B |
More financial data
* Estimated data
Employees
24,561
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/06/25 | 382.80 p | -0.31% | 27,491,700 |
| 23/06/25 | 384.00 p | -0.13% | 11,533,880 |
| 20/06/25 | 384.50 p | +0.52% | 70,145,670 |
| 19/06/25 | 382.50 p | -0.47% | 9,244,048 |
| 18/06/25 | 384.30 p | -0.18% | 25,285,490 |
Delayed Quote London S.E., June 24, 2025 at 04:35 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.828GBP
Average target price
4.247GBP
Spread / Average Target
+10.95%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HLN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition